MedTrace Logo

Project AWARE 2.0 to Improve Awareness, Willingness and Ability for Research and Enrollment in Clinical Research

NCT06343220 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 131

Last updated 2025-12-23

No results posted yet for this study

Summary

The Project AWARE 2.0 Survey is intended to gain knowledge about the feelings, attitudes, and beliefs of HD family members, care partners and others affected by HD towards the way drug trials and observational studies are communicated and conducted.

Conditions

  • Huntington Disease

Sponsors & Collaborators

  • Roche Products Limited

    collaborator UNKNOWN

  • Neurotargeting LLC

    collaborator INDUSTRY

  • Huntington Study Group

    lead NETWORK

Principal Investigators

  • Amy Brown, MD, MS · HSG

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-10
Primary Completion
2025-12-22
Completion
2025-12-22

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06343220 on ClinicalTrials.gov